Cerus
CERS
#7425
Rank
โ‚น40.21 B
Marketcap
โ‚น209.35
Share price
-1.07%
Change (1 day)
33.77%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -โ‚น0.62 Billion

According to Cerus's latest financial reports the company's current earnings are โ‚น0.19 Billion. In 2024 the company made an earning of -โ‚น1.08 Billion, an increase over its 2023 earnings that were of -โ‚น2.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.62 Billion-43.01%
2024 -โ‚น1.08 Billion-58.95%
2023 -โ‚น2.62 Billion-20.74%
2022 -โ‚น3.31 Billion-25.7%
2021 -โ‚น4.45 Billion-11.99%
2020 -โ‚น5.05 Billion-14%
2019 -โ‚น5.88 Billion21.73%
2018 -โ‚น4.83 Billion-0.65%
2017 -โ‚น4.86 Billion-10.96%
2016 -โ‚น5.46 Billion4.24%
2015 -โ‚น5.23 Billion50.99%
2014 -โ‚น3.47 Billion-10.08%
2013 -โ‚น3.86 Billion184.13%
2012 -โ‚น1.36 Billion-7.91%
2011 -โ‚น1.48 Billion
2009 -โ‚น2.08 Billion-24.69%
2008 -โ‚น2.77 Billion-25.2%
2007 -โ‚น3.7 Billion330.54%
2006 -โ‚น0.86 Billion1.49%
2005 -โ‚น0.85 Billion-61.02%
2004 -โ‚น2.17 Billion
2002 -โ‚น5.37 Billion10.02%
2001 -โ‚น4.88 Billion34.25%
2000 -โ‚น3.63 Billion61.02%
1999 -โ‚น2.26 Billion-18.81%
1998 -โ‚น2.78 Billion93.08%
1997 -โ‚น1.44 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚น295.70 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚น1.32 B-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น21.95 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.86 Billion 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA